Skip to main content

Day: July 2, 2024

GAMCO Expects to Report Diluted EPS for the Second Quarter 2024 of $0.59 to $0.65 Per Share

GREENWICH, Conn., July 02, 2024 (GLOBE NEWSWIRE) — GAMCO Investors, Inc. (“GAMI”) (OTCQX: GAMI) announced today that assets under management (“AUM”) were $30.7 billion at June 30, 2024 as compared to an adjusted $30.1 billion at June 30, 2023. AUM would have been $31.2 billion at June 30, 2024 on the same basis as the reported $30.7 billion at June 30, 2023. GAMI expects to report second quarter 2024 diluted earnings in the range of $0.59 to $0.65 per share versus $0.58 per share for the second quarter of 2023. GAMI will be issuing further details on its financial results in early August. About GAMCO Investors, Inc. GAMI is known for its research-driven value approach to equity investing (known as PMV with a CatalystTM). GAMI conducts its investment advisory business principally through two subsidiaries: Gabelli Funds, LLC (24...

Continue reading

Biosimilars Market is Expected to Grow from USD 27.30 Billion 2023 to reach USD 92 Billion in 2031 | SkyQuest Technology

Westford, July 02, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the biosimilars market will attain a value of USD 92 billion by 2031, with a CAGR of 16.4% during the forecast period (2024-2031). The biosimilars market is expected to grow phenomenally with the expected expiry of important biological patents and an increasing imperative to cut healthcare costs. Opportunities in biosimilars market for entering the market, as patent protection for many blockbusters biologic medicines expire, has taken place in the therapeutic areas of oncology, immunology, and endocrinology. This fact is particularly visible because of the important role of biologics in those cures and maintains areas. Download a detailed overview:https://www.skyquestt.com/sample-request/biosimilars-market Browse in-depth TOC on the ” Biosimilars Market “Pages...

Continue reading

QIAGEN N.V. to release results for Q2 2024 and hold webcast

Venlo, The Netherlands, July 02, 2024 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the second quarter 2024. Press release date / time: Wednesday, July 31, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time. Conference call date / time: Thursday, August 1, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time. Three options for joining the conference call Register for call back connection – Click here: Connect meService is available 15 minutes before the call starts Dial-in by phone U.S.: +1 646 828 8193UK: +44 (0)330 165 3655GER: +49 (0)69 6610 2492Conference ID: 8081810To avoid waiting time, please join the event conference 5-10 minutes prior to the start time. Access the audio webcast – Click here: Access Webcast...

Continue reading

Norwegian fitness chain 3T draws on Agillic’s industry experience to enhance membership value

  Norwegian fitness chain 3T draws on Agillic’s vast industry knowledge to enhance its membership experience, improve retention, and to grow its customer lifetime value. 3T is Mid-Norway’s largest fitness chain with workouts for both casual exercise enthusiasts and professional athletes. Besides the typical individual training, group classes, personal trainers, etc., 3T offers events, babysitting during classes, corporate programmes, physiological tests, and runs a clinic with a range of physiotherapy, chiropractic and naprapathy services. To enhance the membership experience, 3T is looking to better cater to the individual needs of their members by delivering the most relevant service and motivation at the right time and will leverage Agillic’s personalisation capabilities and deep industry knowledge to drive higher engagement. Joakim...

Continue reading

Thumzup® Media Corporation Reports 131% Growth in Advertisers Since January 2024

Thumzup GrowthThumzup Media CorporationCompany celebrates surpassing 420 advertisers on its AdTech platform, highlighting Significant GrowthThumzup continues its upward trajectory with an impressive increase in advertiser participationLos Angeles, CA, July 02, 2024 (GLOBE NEWSWIRE) — Thumzup Media Corporation (“Thumzup” or the “Company”) (OTCQB: TZUP), a leader in innovative social media branding and marketing solutions, is excited to announce that it has exceeded 420 advertisers on its proprietary AdTech platform. This milestone signifies a 131% increase in advertisers since the beginning of the year, highlighting the company’s rapid growth and expanding influence. By more than doubling its advertiser base this year alone, Thumzup continues to demonstrate the substantial impact and effectiveness of its unique...

Continue reading

Blender Bites Reports Second Quarter Fiscal 2024 Unaudited Financial Results

VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) — Blender Bites Limited (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL4, WKN: A3DMEJ), announces its unaudited financial results for the three months and six months ended April 30, 2024. All dollar figures are stated in Canadian dollars, unless otherwise indicated. Financial Highlights for the Three Months Ended April 30, 2024:Revenue Growth: Total revenues increased to $1,468,321, up from $217,461 in the comparable period last year, marking an increase of $1,250,860 or 575%. Gross Margin Improvement: The gross margin rose to $411,186, compared to $12,249 for the same period last year, an increase of 3,257%. Expense Reduction: Total expenses were $960,426, down from $2,208,544 in the comparable period, a reduction of $1,248,118 or 56%, including...

Continue reading

Stellantis Invests Additional $55 Million In Archer Following Recent Flight Test Milestone

Stellantis Invests Additional $55 Million In Archer Following Recent Flight Test MilestoneInvestment from Stellantis under the companies’ strategic funding agreement builds on the $39 million worth of open market purchases of Archer stock that Stellantis completed earlier this year, and the $110 million investment made by Stellantis in Archer during 2023 Construction nears completion on Archer’s high-volume manufacturing facility in Covington, GA, which is on track to be completed later this yearAMSTERDAM and SANTA CLARA, CA, July 2, 2024 – Stellantis N.V. (NYSE: STLA / Euronext Milan: STLAM / Euronext Paris: STLAP) and Archer Aviation Inc. (NYSE:ACHR), a leader in electric vertical takeoff and landing (eVTOL) aircraft, today announced Archer has received an additional $55 million investment from Stellantis under the companies’ strategic...

Continue reading

Rail Vision and Railway News to Launch New Collaboration – Podcast Hosting Industry Leaders

Ra’anana, Israel, July 02, 2024 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related market, today announced an upcoming collaboration with Railway-News.com, a leading railway industry news and information portal, for hosting a monthly podcast with industry leaders called “Rail Evolution”. The podcast, which is expected to launch in July 2024, will cover pressing developments in the railway market, discuss by industry experts from across the globe. “This collaboration showcases our relationship with the industry, as we are not only here to sell products and services, but our goal is to also help the industry grow and thrive through multiple channels, The Rail Evolution podcast is one of them.” said Shahar Hania, CEO of...

Continue reading

EnWave to Exhibit at IFT Expo in Chicago

VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today that it will exhibit at IFT First (“IFT”) in Chicago, continuing to bolster the promotion of its proprietary Radiant Energy Vacuum (“REV™”) dehydration technology in the North American market. EnWave has historically had success in attending this tradeshow, connecting with thought leaders from the largest food companies globally. EnWave will educate these professionals about the numerous benefits of REV™ technology, highlighting the many in-market successes demonstrated by the Company’s current royalty partner network.   Many of EnWave’s royalty partners have garnered global recognition for their ability to revolutionize food processing for high-quality snacks...

Continue reading

Myriad Genetics Earns 2024 Great Place To Work® Certification™

SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has received the Great Place To Work Certification for the second year in a row. The certification is based entirely on what current employees say about their experience working at Myriad. This year, 84% of employees said it’s a Great Place To Work – 27 percentage points higher than the average U.S. company. “It’s rare to work somewhere where everyone is so positive and loves their job, but Myriad truly is special,” shared a current Myriad Genetics employee in the anonymous survey. “Every single person I have met so far has been more than pleasant, welcoming and accommodating to me. My opinions and preferences are taken into consideration. I’m not scared to ask questions...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.